Craig Lipset, a clinical trials industry innovator and leader, has joined the MedVector team as a new board member and executive advisor. Lipset, current co-chair of the Decentralized Trials and Research Alliance and an adjunct assistant professor of health informatics at Rutgers University, has been charged with helping MedVector scale its clinical platform offering.
“MedVector is the first platform that addresses the misaligned incentives that stand in the way of physicians talking to their patients about clinical trials,” he said in a statement. “Clinical trial candidates are not medical mysteries. These patients typically have an existing diagnosis, they are on an existing therapy and they value their trusted relationship with an existing local doctor. Enabling these non-investigator physicians to have access to clinical trials as a care option is the ‘holy grail’ of participant enrollment.”